Welcome to our dedicated page for Nano-X Imaging Ltd. news (Ticker: NNOX), a resource for investors and traders seeking the latest updates and insights on Nano-X Imaging Ltd. stock.
NANO-X IMAGING LTD (Nanox) (NASDAQ: NNOX) is a medical imaging technology company that combines imaging hardware, AI-based software, cloud infrastructure, and teleradiology services. The Nanox news feed on this page aggregates company press releases and market updates so readers can follow how Nanox advances its imaging platform, commercial strategy, and capital markets activity over time.
Nanox’s recent news highlights its Nanox.ARC and Nanox.ARC X multi-source digital tomosynthesis systems, including CE Mark certification for Nanox.ARC in Europe and FDA 510(k) clearance for Nanox.ARC X for general use in multiple clinical indications. Articles also cover distribution agreements and collaborations with partners in countries such as France, the Czech Republic, Greece, Romania, Serbia, Montenegro, and Bosnia and Herzegovina, reflecting efforts to expand clinical and commercial deployment of its imaging solutions.
Another key news theme is the growth of Nanox.AI and its imaging analytics portfolio. Press releases describe AI algorithms that analyze routine CT scans for early signs associated with chronic diseases and bone health solutions such as HealthVCF and HealthOST, which have been included in an Early Value Assessment by the UK National Institute for Health and Care Excellence. Updates also discuss acquisitions like VasoHealthcare IT, intended to support deployment of AI solutions across U.S. healthcare facilities.
Investors and analysts can also find financial results announcements, guidance updates, and details of registered direct offerings and other financings, as reported in Nanox’s press releases and related SEC filings. Together, these news items provide insight into Nanox’s commercialization progress, clinical collaborations, AI development roadmap, and capital strategy. Bookmark this page to access an organized stream of Nanox news, from product and partnership updates to financial and regulatory disclosures.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Nano-X Imaging Ltd (Nasdaq: NNOX) has announced a strategic partnership with Ferrum Health to enhance its AI technologies for medical imaging. This collaboration aims to integrate Nanox.AI’s solutions, including the HealthOST and HealthCCSng applications, into Ferrum Health's platform. The partnership focuses on improving the adoption of AI in healthcare, providing advanced analytics for chronic disease detection, and enhancing patient outcomes. Ferrum's platform has already analyzed over 750,000 patient records, further solidifying their position in the AI healthcare space. Both companies aim to democratize access to innovative clinical AI technologies globally.
NANO-X IMAGING LTD (NASDAQ: NNOX) reported its fourth quarter 2022 results, concluding the year with $8.6 million in total revenue. The company generated $2.1 million in Q4, a slight decrease from $2.4 million in Q3. A significant net loss of $44.8 million was noted, largely due to a $36.5 million goodwill impairment. Cash and marketable securities stood at $102.9 million as of December 31, 2022. Key developments included the deployment of a Nanox.ARC system in Ghana and plans for a system in Nigeria, alongside a partnership with Nuance Precision Imaging Network to expand AI solutions. The conference call is scheduled for March 9, 2023.
NANO-X IMAGING LTD (NASDAQ: NNOX) plans to announce its Q4 financial results for the period ending December 31, 2022, on March 9, 2023, before the market opens. CEO Erez Meltzer and CFO Ran Daniel will conduct a conference call at 8:30 a.m. ET to discuss the results and provide a business update. The earnings call can be accessed via registration and a live webcast link available on the company's Investor Relations website. Nanox focuses on making diagnostic imaging affordable and accessible worldwide, utilizing its proprietary Nanox.ARC and Nanox.CLOUD technologies.
NANO-X IMAGING LTD (Nasdaq: NNOX) announced the connection of its subsidiary Nanox.AI to the Nuance Precision Imaging Network on February 14, 2023. This collaboration enhances care team communications and integrates AI insights into clinical workflows, aiming to improve healthcare outcomes and reduce costs. Nanox.AI focuses on addressing chronic diseases through AI-driven imaging solutions, including FDA-cleared products for bone and cardiovascular health. Powered by Microsoft Azure, the Nuance network serves over 12,000 healthcare facilities and supports 80% of U.S. radiologists, potentially increasing the reach of Nanox's innovative imaging technologies.